by rdbiomed | Mar 5, 2021 | Company Updates, Latest Pepsin Research
We’re excited to hear that Peptest has proved valuable in helping identify symptoms of ‘silent reflux’ at NHS respiratory clinics at the Bristol Royal Infirmary. Many people associate reflux with symptoms, such as heartburn or acid reflux, but it can also cause... 
by rdbiomed | Feb 15, 2021 | Latest Pepsin Research, reflux treatments
Measuring salivary pepsin levels has the potential to reduce time to diagnose acid reflux, minimise the use of proton pump inhibitor (PPI) therapy, and streamline care for patients with symptoms. That’s the findings of a new study undertaken at two care centres at the... 
by rdbiomed | Oct 22, 2020 | Latest Pepsin Research
Peptest is a useful, non-invasive diagnostic test for self-diagnosing reflux related symptoms, a study published in the EC Gastroenterology and Digestive System journal has highlighted. Many people suffering from troublesome reflux-related symptoms, such as... 
by rdbiomed | Oct 19, 2020 | Latest Pepsin Research
Salivary pepsin detection is hailed a ‘simpler, more cost-effective and less traumatic universal first-line alternative’ to 24-hour pH monitoring in diagnosing laryngopharyngeal reflux disease (LPR). For the first time, researchers have simultaneously evaluated the... 
by rdbiomed | Oct 12, 2020 | Latest Pepsin Research
Eye examinations could improve the management of patients with laryngopharyngeal reflux disease (LPR), according to a new study. LPR symptoms typically consist of hoarseness, sore throat, the feeling of a lump in the throat and throat clearing. However, it is also... 
by rdbiomed | Sep 4, 2020 | Latest Pepsin Research
Laryngopharyngeal reflux (LPR) – when gastric contents refluxes into the larynx/pharynx – can be diagnosed using a salivary pepsin test, says a study published in the International Archives of Otorhinolaryngology. Pepsin is an enzyme in gastric juice that...
Recent Comments